During the government’s opening statement in the fraud and conspiracy trial of Theranos founder Elizabeth Holmes on Wednesday, a federal prosecutor accused the defendant of “lying and cheating.” Holmes is facing 10 counts of wire fraud and two counts of conspiracy. (Reuters)

Cancer startup Replicate Bioscience is conducting a “light rebranding” to focus on mRNA technology. The company hopes to use mRNA technology to spur the body’s cells to battle cancer. (STAT)

The COVID-19 pandemic has set back prevention and treatment of HIV, tuberculosis and malaria around the world, according to a new report by nonprofit organization AVAC. The report found that the pandemic compromised gains made in recent years to fight the illnesses. (The New York Times)

Sanofi has acquired biopharma Kadmon for $1.9 billion. Kadmon’s Rezurock, a newly approved treatment for chronic graft-versus-host disease, was among the assets motivating the deal. (Endpoints News)

Confusion over booster shot recommendations has left vaccinated people wondering when, if at all, they should receive a third dose. While President Biden has pushed for booster shots to be rolled out to adults by September 20, the Food and Drug Administration has yet to officially approve the White House’s plan. (The Washington Post)